Apr. 29 at 12:24 PM
$SCL
Stepan Company reported strong Q1 2025 results with net income up 42% to
$19.7 million. The company achieved notable growth with global sales volume increasing 4% year-over-year and adjusted EBITDA rising 12% to
$57.5 million.
Key highlights include:
Net sales increased 8% to
$593.3 million
Surfactants segment saw 10% growth with sales of
$430.3 million
Polymers segment remained flat at
$146.1 million despite 7% volume growth
Specialty Products grew 11% to
$16.8 million
The company's new Pasadena, Texas facility is now operational, supporting specialty alkoxylation business growth. CEO Luis E. Rojo expressed optimism about continued earnings improvement, citing double-digit volume growth in Agricultural and Oilfield markets. Despite negative free cash flow of
$25.8 million due to higher working capital requirements, management remains confident about delivering full-year adjusted EBITDA growth and positive free cash flow in 2025.
